The Development of a Microbial Challenge Test with Acholeplasma laidlawii To Rate Mycoplasma-Retentive Filters by Filter Manufacturers

References

1. 1.↵
   1. Maniloff J.,
   2. McElhaney N.,
   3. Finch L.,
   4. Baseman J.

   Mycoplasmas: Molecular Biology and Pathogenesis. ASM Press: Washington, DC, 1992.
2. 2.↵
   1. Hayflick L.

   The Mycoplasmatales and the L-Phase Bacteria. Appleton-Century-Crofts: New York, 1969.
3. 3.↵
   1. Molander C. W.,
   2. Kagan B. M.,
   3. Weinberger H. J.,
   4. Heimlich E. M.,
   5. Busser R. J.

   Induction by antibiotics and comparative sensitivity of L-phase variants of Staphylococcus aureus. J. Bacteriol. 1964, 88 (3), 591–594.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Nimmo L. N.,
   2. Blazevic D. J.

   Selection of media for the isolation of common bacterial L-phase organisms from a clinical specimen. Appl. Microbiol. 1969, 18 (4), 535–541.

   OpenUrlPubMed
5. 5.↵
   1. Balish M. F.

   Subcellular structures of mycoplasmas. Front. Biosci. 2006, 11, 2017–2027.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Rottem S.

   Interaction of mycoplasmas with host cells. Physiol. Rev. 2003, 83 (2), 417–32.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Saito Y.,
   2. McElhaney R. N.

   Membrane lipid biosynthesis in Acholeplasma laidlawii B: incorporation of exogenous fatty acids into membrane glyco- and phospholipids by growing cells. J. Bacteriol. 1977, 132 (2), 485–496.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Folmsbee M.,
   2. Noah C.,
   3. McAlister M.

   Nutritional effects on the growth, cell size and resistance to stress of Acholeplasma laidlawii. PDA J. Sci. Technol. 2010, 64 (6), 581–592.

   OpenUrl
9. 9.↵
   1. Wieslander A.,
   2. Rilfors L.

   Qualitative and quantitative variations of membrane lipid species in Acholeplasma laidlawii A. Biochim. Biophys. Acta 1977, 466 (2), 336–346.

   OpenUrlPubMed
10. 10.↵
    1. Razin S.,
    2. Tourtellotte M. E.,
    3. McElhaney R. N.,
    4. Pollack J. D.

    Influence of lipid components of Mycoplasma laidlawii membranes on osmotic fragility of cells. J. Bacteriol. 1966, 91 (2), 609–616.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Rottem S.,
    2. Panos C.

    The effect of long chain fatty acid isomers on growth, fatty acid composition and osmotic fragility of Mycoplasma laidlawii A. J. Gen. Microbiol. 1969, 59 (3), 317–328.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. McElhaney R. N.,
    2. Tourtellotte M. E.

    Mycoplasma membrane lipids: variations in fatty acid composition. Science 1969, 164 (878), 433–434.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Huang L.,
    2. Jaquet D. D.,
    3. Haug A.

    Effect of fatty acyl chain length on some structural and functional parameters of Acholeplasma membranes. Can. J. Biochem. 1974, 52 (6), 483–490.

    OpenUrlPubMed
14. 14.↵
    1. Wieslander A.,
    2. Christiansson A.,
    3. Rilfors L.,
    4. Lindblom G.

    Lipid bilayer stability in membranes. Regulation of lipid composition in Acholeplasma laidlawii as governed by molecular shape. Biochemistry 1980, 19 (16) 3650–3655.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Rilfors L.,
    2. Wikander G.,
    3. Wieslander A.

    Lipid acyl chain-dependent effects of sterols in Acholeplasma laidlawii membranes. J. Bacteriol. 1987, 169 (2), 830–838.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Wieslander A.,
    2. Nordstrom S.,
    3. Dahlqvist A.,
    4. Rilfors L.,
    5. Lindblom G.

    Membrane lipid composition and cell size of Acholeplasma laidlawii strain A are strongly influenced by lipid acyl chain length. Eur. J. Biochem. 1995, 227 (3), 734–744.

    OpenUrlPubMedWeb of Science
17. 17.↵
    1. Lindblom G.,
    2. Hauksson J. B.,
    3. Rilfors L.,
    4. Bergenstahl B.,
    5. Wieslander A.,
    6. Eriksson P. O.

    Membrane lipid regulation in Acholeplasma laidlawii grown with saturated fatty acids. Biosynthesis of a triacylglucolipid forming reversed micelles. J. Biol. Chem. 1993, 268 (22), 16198–16207.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Folmsbee M.,
    2. Howard G.,
    3. McAlister M.

    Nutritional effects of culture media on mycoplasma cell size and removal by filtration. Biologicals 2010, 38 (2), 214–217.

    OpenUrlPubMed
19. 19.↵
    1. Bates S.,
    2. Nguyen N.,
    3. Lentine K. R.

    Development of serum-free media for the cultivation and recovery of Acholeplasma laidlawii used for challenge testing sterilizing-grade filters used in biopharmaceutical applications. PDA J. Pharm. Sci. Technol. 2008, 62 (6), 402–420.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Krantz M.,
    2. Nordlander B.,
    3. Valadi H.,
    4. Johansson M.,
    5. Gustafsson L.,
    6. Hohmann S.

    Anaerobicity prepares Saccharomyces cerevisiae cells for faster adaptation to osmotic shock. Eukaryot Cell 2004, 3 (6), 1381–1390.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Jenkins D. E.,
    2. Chaisson S. A.,
    3. Matin A.

    Starvation-induced cross protection against osmotic challenge in Escherichia coli. J. Bacteriol. 1990, 172 (5), 2779–2781.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Kjelleberg S.

    Starvation in Bacteria; Plenum Press: New York, 1993.
23. 23.↵
    1. Weart R. B.,
    2. Lee A. H.,
    3. Chien A. C.,
    4. Haeusser D. P.,
    5. Hill N. S.,
    6. Levin P. A.

    A metabolic sensor governing cell size in bacteria. Cell 2007, 130 (2), 335–347.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Givskov M.,
    2. Eberl L.,
    3. Moller S.,
    4. Poulsen L. K.,
    5. Molin S.

    Responses to nutrient starvation in Pseudomonas putida KT2442: analysis and general cross-protection, cell shape, and macromolecular content. J. Bacteriol. 1994, 176 (1), 7–14.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Velimirov B.

    Nanobacteria, ultramicrobacteria and starvation forms: a search for the smallest metabolizing bacterium. Microbes and Environment 2001, 16 (2), 67–77.

    OpenUrl
26. 26.↵
    1. Brown M. R.,
    2. Williams P.

    The influence of environment on envelope properties affecting survival of bacteria in infections. Ann. Rev. Microbiol. 1985, 39 (1), 527–556.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Williams P.

    Role of the cell envelope in bacterial adaptation to growth in vivo in infections. Biochimie 1988, 70 (8), 987–1011.

    OpenUrlPubMed
28. 28.↵
    1. McElwain M. C.,
    2. Williams M. V.,
    3. Pollack J. D.

    Acholeplasma laidlawii B-PG9 adenine-specific purine nucleoside phosphorylase that accepts ribose-1-phosphate, deoxyribose-1-phosphate, and xylose-1-phosphate. J. Bacteriol. 1988, 170 (2), 564–547.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Cronholm K.,
    2. Bates S.,
    3. Nguyen N.,
    4. Leahy A.,
    5. Blanchard M.,
    6. Lentine K. R.

    Validation of a microbiological method using Acholeplasma laidlawii for assessing performance of microporous membranes for mycoplasma clearance. PDA J. Pharm. Sci. Technol. 2009, 63 (5), 438–461.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Windsor H. M.,
    2. Windsor G. D.,
    3. Noordergraaf J. H.

    The growth and long term survival of Acholeplasma laidlawii in media products used in biopharmaceutical manufacturing. Biologicals 2010, 38 (2), 204–210.

    OpenUrlPubMed
31. 31.↵
    1. Drexler H. G.,
    2. Uphoff C. C.

    Mycoplasma contamination of cell cultures: incidence, sources, effects, detection, elimination and prevention. Cytotechnology 2006, 39 (2), 75–90.

    OpenUrl
32. 32.↵
    1. Potts B.

    Proceedings from the PDA Workshop on Mycoplasma Contamination by Plant Peptones. PDA: San Diego, CA, 2007; pp 1–257.
33. 33.↵
    ASTM. Standard Test Method for Determining Bacterial Retention of Membrane Filters Utilized for Liquid Filtration American Society for Testing and Materials (ASTM) 2013, ASTM Standard F838–05 (Reapproved 2013).
34. 34.↵
    PDA. PDA Technical Report No 26, Sterilizing Filtration of Liquids. PDA J Pharm Sci Technol. 2008, 62 (S-5), 1–60.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    Food and Drug Administration (FDA) Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice. FDA: Rockville, MD, 2004.
36. 36.↵
    The Rules Governing Medicinal Products in the European Union. Volume 4. Medicinal Products for Human and Veterinary Use: Good Manufacturing Practices Annex 1 Manufacture of sterile Medicinal Products. Belgium, 2003.
37. 37.↵
    Aseptic Processing of Health Care Products—Part 2: Filtration. In ISO 13408-2:2003(E), Standardization. Geneva, Switzerland, 2003.